Canlyniadau Chwilio am Awdur

1

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome gan Laure Morin‐Papunen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen

Cyhoeddwyd 1998

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study gan K Rautio, Juha S. Tapanainen, Aimo Ruokonen, Laure Morin‐Papunen

Cyhoeddwyd 2006

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, A Ruokonen, Juha S. Tapanainen

Cyhoeddwyd 2000

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Endocrine and Metabolic Effects of MetforminVersusEthinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study1 gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen, Juha S. Tapanainen

Cyhoeddwyd 2000

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome gan Terhi Piltonen, Laure Morin‐Papunen, Riitta Koivunen, Antti Perheentupa, Aimo Ruokonen, Juha S. Tapanainen

Cyhoeddwyd 2005

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome gan Laure Morin‐Papunen, K Rautio, Aimo Ruokonen, Pirjo Hedberg, M. Puukka, Juha S. Tapanainen

Cyhoeddwyd 2003

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Adrenal Androgen Production Capacity Remains High up to Menopause in Women with Polycystic Ovary Syndrome gan Johanna Puurunen, Terhi Piltonen, Päivi Jaakkola, Aimo Ruokonen, Laure Morin‐Papunen, Juha S. Tapanainen

Cyhoeddwyd 2009

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

MetforminVersusEthinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen, Juha S. Tapanainen

Cyhoeddwyd 2003

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS gan Johanna Puurunen, Terhi Piltonen, Laure Morin‐Papunen, Antti Perheentupa, Ilkka Y. Järvelä, Aimo Ruokonen, Juha S. Tapanainen

Cyhoeddwyd 2011

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study gan Meri‐Maija Ollila, Riikka K. Arffman, Elisa Korhonen, Laure Morin‐Papunen, Stephen Franks, Juhani Junttila, Terhi Piltonen

Cyhoeddwyd 2023

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study gan Johanna Puurunen, Terhi Piltonen, Katri Puukka, Aimo Ruokonen, Markku J. Savolainen, Risto Bloigu, Laure Morin‐Papunen, Juha S. Tapanainen

Cyhoeddwyd 2013

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

TBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia gan Maria Sandbacka, Hannele Laivuori, Érika L. Freitas, Mervi Halttunen, Varpu Jokimaa, Laure Morin‐Papunen, Carla Rosenberg, Kristiina Aittomäki

Cyhoeddwyd 2013

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

Obesity Represses <scp>CYP2R1</scp>, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues gan Mahmoud‐Sobhy Elkhwanky, Outi Kummu, Terhi Piltonen, Johanna Laru, Laure Morin‐Papunen, Maija Mutikainen, Pasi Tavi, Jukka Hakkola

Cyhoeddwyd 2020

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study gan S. West, Hany Lashen, Aini Bloigu, Stephen Franks, Katri Puukka, Aimo Ruokonen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Laure Morin‐Papunen

Cyhoeddwyd 2014

Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study gan Meri‐Maija Ollila, Terhi Piltonen, Katri Puukka, Aimo Ruokonen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Stephen Franks, Laure Morin‐Papunen

Cyhoeddwyd 2015

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
16

Former long‐term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: A prospective, population‐based cohort study gan Maria‐Elina Mosorin, Meri‐Maija Ollila, Tanja Nordström, Jari Jokelainen, Terhi Piltonen, Juha Auvinen, Laure Morin‐Papunen, Juha S. Tapanainen

Cyhoeddwyd 2023

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
17

Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study gan Meri‐Maija Ollila, Kari Kaikkonen, Marjo‐Riitta Järvelin, Heikki V. Huikuri, Juha S. Tapanainen, Stephen Franks, Terhi Piltonen, Laure Morin‐Papunen

Cyhoeddwyd 2018

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
18

Polycystic ovary syndrome and risk factors for gestational diabetes gan Sanna Mustaniemi, Marja Vääräsmäki, Johan G. Eriksson, Mika Gissler, Hannele Laivuori, Hilkka Ijäs, Aini Bloigu, Eero Kajantie, Laure Morin‐Papunen

Cyhoeddwyd 2018

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
19

Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms gan Salla Karjula, Laure Morin‐Papunen, Stephen Franks, Juha Auvinen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Jari Jokelainen, Jouko Miettunen, Terhi Piltonen

Cyhoeddwyd 2020

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
20

Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a r... gan Terhi Piltonen, Johanna Puurunen, Pär Hedberg, Aimo Ruokonen, Shivaprakash Jagalur Mutt, Karl‐Heinz Herzig, A Nissinen, Laure Morin‐Papunen, Juha S. Tapanainen

Cyhoeddwyd 2012

Cael y testun llawn Cael y testun llawn
Artigo

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome gan Laure Morin‐Papunen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study gan K Rautio, Juha S. Tapanainen, Aimo Ruokonen, Laure Morin‐Papunen

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, A Ruokonen, Juha S. Tapanainen

Endocrine and Metabolic Effects of Metformin<i>Versus</i>Ethinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study<sup>1</sup> gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen, Juha S. Tapanainen

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome gan Terhi Piltonen, Laure Morin‐Papunen, Riitta Koivunen, Antti Perheentupa, Aimo Ruokonen, Juha S. Tapanainen

Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome gan Laure Morin‐Papunen, K Rautio, Aimo Ruokonen, Pirjo Hedberg, M. Puukka, Juha S. Tapanainen

Adrenal Androgen Production Capacity Remains High up to Menopause in Women with Polycystic Ovary Syndrome gan Johanna Puurunen, Terhi Piltonen, Päivi Jaakkola, Aimo Ruokonen, Laure Morin‐Papunen, Juha S. Tapanainen

Metformin<i>Versus</i>Ethinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen, Juha S. Tapanainen

Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS gan Johanna Puurunen, Terhi Piltonen, Laure Morin‐Papunen, Antti Perheentupa, Ilkka Y. Järvelä, Aimo Ruokonen, Juha S. Tapanainen

Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study gan Meri‐Maija Ollila, Riikka K. Arffman, Elisa Korhonen, Laure Morin‐Papunen, Stephen Franks, Juhani Junttila, Terhi Piltonen

TBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia gan Maria Sandbacka, Hannele Laivuori, Érika L. Freitas, Mervi Halttunen, Varpu Jokimaa, Laure Morin‐Papunen, Carla Rosenberg, Kristiina Aittomäki

Obesity Represses <scp>CYP2R1</scp>, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues gan Mahmoud‐Sobhy Elkhwanky, Outi Kummu, Terhi Piltonen, Johanna Laru, Laure Morin‐Papunen, Maija Mutikainen, Pasi Tavi, Jukka Hakkola

Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study gan Meri‐Maija Ollila, Terhi Piltonen, Katri Puukka, Aimo Ruokonen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Stephen Franks, Laure Morin‐Papunen

Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study gan Meri‐Maija Ollila, Kari Kaikkonen, Marjo‐Riitta Järvelin, Heikki V. Huikuri, Juha S. Tapanainen, Stephen Franks, Terhi Piltonen, Laure Morin‐Papunen

Polycystic ovary syndrome and risk factors for gestational diabetes gan Sanna Mustaniemi, Marja Vääräsmäki, Johan G. Eriksson, Mika Gissler, Hannele Laivuori, Hilkka Ijäs, Aini Bloigu, Eero Kajantie, Laure Morin‐Papunen

Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms gan Salla Karjula, Laure Morin‐Papunen, Stephen Franks, Juha Auvinen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Jari Jokelainen, Jouko Miettunen, Terhi Piltonen

Canlyniadau Chwilio - Laure Morin‐Papunen

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome gan Laure Morin‐Papunen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study gan K Rautio, Juha S. Tapanainen, Aimo Ruokonen, Laure Morin‐Papunen

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, A Ruokonen, Juha S. Tapanainen

Endocrine and Metabolic Effects of Metformin<i>Versus</i>Ethinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study<sup>1</sup> gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen, Juha S. Tapanainen

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome gan Terhi Piltonen, Laure Morin‐Papunen, Riitta Koivunen, Antti Perheentupa, Aimo Ruokonen, Juha S. Tapanainen

Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome gan Laure Morin‐Papunen, K Rautio, Aimo Ruokonen, Pirjo Hedberg, M. Puukka, Juha S. Tapanainen

Adrenal Androgen Production Capacity Remains High up to Menopause in Women with Polycystic Ovary Syndrome gan Johanna Puurunen, Terhi Piltonen, Päivi Jaakkola, Aimo Ruokonen, Laure Morin‐Papunen, Juha S. Tapanainen

Metformin<i>Versus</i>Ethinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study gan Laure Morin‐Papunen, Ilkka Vauhkonen, Riitta Koivunen, Aimo Ruokonen, Hannu Martikainen, Juha S. Tapanainen

Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS gan Johanna Puurunen, Terhi Piltonen, Laure Morin‐Papunen, Antti Perheentupa, Ilkka Y. Järvelä, Aimo Ruokonen, Juha S. Tapanainen

Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study gan Meri‐Maija Ollila, Riikka K. Arffman, Elisa Korhonen, Laure Morin‐Papunen, Stephen Franks, Juhani Junttila, Terhi Piltonen

TBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia gan Maria Sandbacka, Hannele Laivuori, Érika L. Freitas, Mervi Halttunen, Varpu Jokimaa, Laure Morin‐Papunen, Carla Rosenberg, Kristiina Aittomäki

Obesity Represses <scp>CYP2R1</scp>, the Vitamin D 25‐Hydroxylase, in the Liver and Extrahepatic Tissues gan Mahmoud‐Sobhy Elkhwanky, Outi Kummu, Terhi Piltonen, Johanna Laru, Laure Morin‐Papunen, Maija Mutikainen, Pasi Tavi, Jukka Hakkola

Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study gan Meri‐Maija Ollila, Terhi Piltonen, Katri Puukka, Aimo Ruokonen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Stephen Franks, Laure Morin‐Papunen

Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study gan Meri‐Maija Ollila, Kari Kaikkonen, Marjo‐Riitta Järvelin, Heikki V. Huikuri, Juha S. Tapanainen, Stephen Franks, Terhi Piltonen, Laure Morin‐Papunen

Polycystic ovary syndrome and risk factors for gestational diabetes gan Sanna Mustaniemi, Marja Vääräsmäki, Johan G. Eriksson, Mika Gissler, Hannele Laivuori, Hilkka Ijäs, Aini Bloigu, Eero Kajantie, Laure Morin‐Papunen

Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms gan Salla Karjula, Laure Morin‐Papunen, Stephen Franks, Juha Auvinen, Marjo‐Riitta Järvelin, Juha S. Tapanainen, Jari Jokelainen, Jouko Miettunen, Terhi Piltonen

Offerynnau Chwilio:

Pynciau Perthynol